Geode Capital Management
KRSA

Geode Capital Management’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

Geode Capital Management’s Portfolio KRSA Stock Details KRSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$155K Sell
6,550
-5,529
-46% -$17.9K ﹤0.01% 3993
2026
Q1 		$130K Buy
12,079
+5,893
+95% +$8.39K ﹤0.01% 4065
2025
Q4 		$55K Buy
6,186
+878
+17% +$1.57K ﹤0.01% 4218
2025
Q3 		$85.5K Buy
5,308
+632
+14% +$1.72K ﹤0.01% 4169
2025
Q2 		$95.3K Buy
4,676
+161
+4% +$481 ﹤0.01% 4071
2025
Q1 		$78.1K Sell
4,515
-31
-0.7% -$92 ﹤0.01% 4099
2024
Q4 		$102K Sell
4,546
-298
-6% -$830 ﹤0.01% 4091
2024
Q3 		$87.5K Sell
4,844
-10
-0.2% -$29 ﹤0.01% 4144
2024
Q2 		$77.5K Buy
4,854
+271
+6% +$770 ﹤0.01% 4196
2024
Q1 		$103K Buy
4,583
+117
+3% +$374 ﹤0.01% 4153
2023
Q4 		$105K Buy
4,466
+73
+2% +$211 ﹤0.01% 4177
2023
Q3 		$105K Buy
4,393
+147
+3% +$530 ﹤0.01% 4235
2023
Q2 		$122K Buy
4,246
+16
+0.4% +$83 ﹤0.01% 4254
2023
Q1 		$257K Buy
4,230
+39
+0.9% +$492 ﹤0.01% 3922
2022
Q4 		$385K Buy
4,191
+21
+0.5% +$248 ﹤0.01% 3795
2022
Q3 		$502K Buy
4,170
+72
+2% +$1.24K ﹤0.01% 3725
2022
Q2 		$314K Sell
4,098
-69
-2% -$988 ﹤0.01% 4007
2022
Q1 		$647K Buy
4,167
+125
+3% +$3.01K ﹤0.01% 3816
2021
Q4 		$973K Buy
4,042
+537
+15% +$25.4K ﹤0.01% 3738
2021
Q3 		$1.51M Buy
3,505
+756
+28% +$49.5K ﹤0.01% 3485
2021
Q2 		$1.5M Sell
2,749
-729
-21% -$45.6K ﹤0.01% 3397
2021
Q1 		$1.36M Buy
3,478
+379
+12% +$28.5K ﹤0.01% 3430
2020
Q4 		$1.33M Buy
3,099
+578
+23% +$39.4K ﹤0.01% 3273
2020
Q3 		$2.15M Buy
2,521
+263
+12% +$30.1K ﹤0.01% 2843
2020
Q2 		$1.87M Sell
2,258
-49
-2% -$4.1K ﹤0.01% 2882
2020
Q1 		$855K Buy
2,307
+161
+8% +$11.5K ﹤0.01% 3077
2019
Q4 		$817K Buy
2,146
+390
+22% +$36.4K ﹤0.01% 3346
2019
Q3 		$2.98M Buy
1,756
+31
+2% +$6.7K ﹤0.01% 2695
2019
Q2 		$2.76M Buy
+1,725
New +$488K ﹤0.01% 2744

Other funds holding KRSA

KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RC
Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management's KRSA Position: Q2 2026 in Review

Geode Capital Management reduced its Korsana Biosciences, Inc. Common Stock (KRSA) stake by 46% in Q2 2026, selling an estimated $17.9K and leaving 6,550 shares worth $155K. The position accounts for ﹤0.01% of the portfolio, ranked #3993.

Geode Capital Management first reported a position in KRSA in Q2 2019 and has held it in 29 quarters since. The position peaked at $2.98M in Q3 2019. 21 funds tracked by Wall St. Rank hold KRSA as of Q2 2026.

  • Geode Capital Management held 6,550 shares of Korsana Biosciences, Inc. Common Stock worth $155K as of Q2 2026.
  • Geode Capital Management sold 5,529 Korsana Biosciences, Inc. Common Stock shares in Q2 2026, an estimated $17.9K.
  • Korsana Biosciences, Inc. Common Stock made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3993 holding.
  • Geode Capital Management first reported a position in Korsana Biosciences, Inc. Common Stock in Q2 2019 and has held it in 29 quarters since.
  • Geode Capital Management's Korsana Biosciences, Inc. Common Stock position peaked at $2.98M in Q3 2019.
  • 21 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.